MustGrow Commences Funded Study On Tobacco Crop Protection Program

MustGrow Biologics (CSE: MGRO) announced this morning the commencement of a tobacco crop protection research program. The program is being funded by the Canadian Tobacco Research Foundation, with the goal of targeting tobacco cyst nematodes and root-lesion nematodes.

A collaborative research program is currently underway between the foundation and MustGrow as a means of building on the firms previous achievements that include third party studies using MustGrow’s patented mustard-derived bio-pesticide that demonstrated 100% control of soil-borne diseases and pathogens that include nematodes. Corporate collaboration discussions with tobacco industry leaders are also underway.

The study will see MustGrow’s patented liquid format utilized for testing of effectiveness against the disease, whereas previous testing has largely focused on the granular product format. The use of liquid format enables the bio-pesticide to be applied via spraying, which is often a more favourable alternative for application. The product will be evaluated in both pre-planting and post-planting applications, targeting tobacco cyst nematodes after hatching.

Nematodes are parasitic worms that infect the root system of a plant, reducing water and nutrient movement within the plant and stunting growth, resulting in lower yields. Yield destruction from the parasite has been reported in eleven tobacco-producing countries, which includes both Canada and the US. Global tobacco crop loss from the parasite is estimated as being US$4.2 billion, or 15%. Nematodes continue to do this damage to tobacco plants despite the use of synthetic chemical pesticides, which continue to be deregistered or banned due to the harmful effects of such pesticides.

A timeline for the completion of the collaborative research program has not been provided, however the study is currently underway.

MustGrow Biologics last traded at $0.32 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Uranium Is Back On America’s Radar | Corey Dias –  Anfield Energy

The Russell Will Lead the Next Market Crash!? | John Feneck

The Global Conflict Has Already Started | Bryan Cunningham

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

MustGrow Biologics To Raise $2.0 Million In Private Placement

MustGrow Biologics (CSE: MGRO) this morning announced it will be conducting a small financing. The...

Monday, September 13, 2021, 07:55:55 AM

MustGrow Biologics: Three Things To Know

MustGrow Biologics (CSE: MGRO) has been on a high volume tear as of late, with...

Wednesday, February 19, 2020, 12:21:45 PM

MustGrow Successfully Imports TerraMG To Colombia For Laboratory Testing

MustGrow Biologics (CSE: MGRO) announced this morning that it has successfully imported its flagship TerraMG...

Tuesday, June 16, 2020, 09:46:18 AM

MustGrow: Organic Disease Control – The Daily Dive

Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow...

Monday, August 30, 2021, 01:30:00 PM

MustGrow Sees Positive Results From Tobacco Field Trials

MustGrow Biologics (CSE: MGRO) this morning reported on results for the use of its mustard-based...

Monday, April 12, 2021, 08:16:06 AM